C the Signs

🚀 Exciting Opportunity Alert! 🚀 We're on the lookout for a dynamic Healthcare Business Development Representative to join our team in the United Kingdom. If you're passionate about healthcare and have a knack for building relationships, this could be the perfect role for you! 🌟 Why Join Us? 🌟 - Innovative and supportive work environment - Opportunities for professional growth - Make a meaningful impact in the healthcare industry Don't miss out – apply today! Or, if you know someone who would be a great fit, please share this post with your network. 🔗 https://lnkd.in/eUyFK8SZ #Hiring #HealthcareJobs #BusinessDevelopment #CareerOpportunity #JoinOurTeam #CtheSigns

🌟 We are super excited to be at #NHSConfedExpo today and tomorrow in Manchester! 🚀 Come and meet us on stand LT4, hosted by the Health Innovation Network and Health Innovation East. Don't miss the chance to connect with Miles Payling and Dr Jude Gordon from our team! We’re eager to hear about local challenges and priorities in cancer across the UK and share how C the Signs' AI technology can deliver earlier, faster, and more effective care to patients. 💪 Swing by for live demos of our platform, grab some info on our groundbreaking research and work across the UK, and let’s make a difference together! See you there! 👋✨

We are thrilled to have presented the data from our landmark study at the American Society of Clinical Oncology (ASCO) 2024, with findings showing an improvement in cancer detection rates of over 12% in GP practices utilising C the Signs in Ipswich and East Suffolk🙌 It was an honour to co-author this study, with Dr Peter Holloway and Claire Corbett from NHS Suffolk and North East Essex Integrated Care Board (SNEE), and Seema Dadhania from Imperial College London 👏 This study, conducted in partnership with SNEE, with the support of East of England Cancer Alliance and Health Innovation East, underscores the importance of integrating cutting-edge technologies into primary care to improve cancer detection rates and facilitate early-stage diagnosis. Following this study in Ipswich and East Suffolk, C the Signs has now been rolled out to the entire ICB, serving 1 million patients 🙌 We take immense pride in our NHS partnerships, particularly in the diligent efforts of primary care teams tirelessly working to identify cancer at its earliest stages across the regions 💙 You can read the abstract here in the Journal of Clinical Oncology ⬇️ https://lnkd.in/e3tWC7YX

🎉 We’re super excited to be attending the NHS Confederation Expo 2024 in Manchester on 12-13th June, in the Health Innovation Network Learning Zone! 🎉 We look forward to connecting with our incredible colleagues from the Health Innovation Network and the NHS, all dedicated to improving outcomes for cancer patients. Visit us at Stand LT4 to say hi 👋 and learn more about the innovative strides we're making at C the Signs in cancer care and early diagnosis. Interested to chat more? Message Dr Jude Gordon or Miles Payling to arrange a time! 📩

🌟 Exciting News! 🌟 We are thrilled to announce that C the Signs has been selected by Google as one of just 24 startups to join the prestigious Google for Startups Growth Academy: AI for Health! 🎉 The program kicked off last week in Paris, featuring inspirational talks from Karen DeSalvo, Antoine Tesniere, and Joëlle Barral, who shared their forward-thinking perspectives on the future of healthcare. A huge thank you to the Google for Startups team, with a special thank you to Liron Sela Maskit, Noam Feinstein, Yuval Passov, and Sofía Benjumea for organising such an outstanding program! The insights and workshops led by our mentors Alia Lamaadar, Lior Shoham, Gali Bloch Liran, Dillion Obika, A.Mahdy Abdelaziz, and many others were invaluable. We’re eager and excited to take the next steps in this incredible journey! 🚀 #GoogleStartups #AIforHealth #CTtheSigns #HealthcareInnovation #GrowthAcademy

We’ve had an incredible few days in Charlotte, North Carolina, delving into the groundbreaking work at Atrium Health as part of the CancerX Moonshot program 🚀 This event united experts from Atrium Health, industry, academia, and government, all dedicated to transforming cancer outcomes for all. Atrium Health, the third-largest non-profit health system in the U.S., is a renowned leader in cancer care. Their commitment to community and health equity aligns perfectly with C the Signs’ mission to ensure high-quality, equitable care for everyone. Atrium Health’s passionate, person-centered teams are pioneering new technologies and innovations to enhance cancer outcomes and patient experiences across their community. We deeply valued the insights shared by these experts and are thrilled to collaborate with Atrium Health to advance early cancer detection and screening for North Carolina’s most under-served communities. Stay tuned for more updates! 🙏 Thank you to Carol Farhangfar and Benjamin Tingey, and all those involved in putting together this fantastic event! With a special shout out to Mellisa Wheeler - it was great to meet her incredible team focused on community lung cancer screening 🌟 Advocate Health, Digital Medicine Society (DiMe), Ruben Mesa, MD, Rasu Shrestha MD MBA,  Office of the National Coordinator for Health Information Technology (ONC), Office of the Assistant Secretary for Health (OASH), and MassChallenge, The Blue Box Biomedical Solutions, Curiva, EnteroTrack LLC., Gesund.ai, Gray Oncology Solutions, Lind, Mika, Navya Care, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, XanthosHealth 🌟

🎉 We are delighted to announce that we have been nominated for the ‘Best Digital Health Solution’ at the 2024 Prix Galien UK Awards! 🎉 The Galien Foundation, a globally renowned institution dedicated to honouring innovators in life sciences, has recognised our work. The Prix Galien Award is often referred to as the Nobel Prize in biopharmaceutical research, making this nomination an extraordinary honour for us. 🙌 "These individuals and organisations embody the essence of healthcare excellence, demonstrating profound dedication to improving the human condition. Their remarkable contributions serve as beacons of hope and progress, shaping the future of healthcare for generations to come." said Professor Sir Munir Pirmohamed, David Weatherall Chair of Medicine at the University of Liverpool and the NHS Chair of Pharmacogenetics, Chair of the Prix Galien UK Committee. Launched in 1990, the Prix Galien UK Awards honour winners chosen by an expert committee comprising some of the UK’s leading healthcare professionals. This recognition underscores the importance of research-driven innovation in advancing healthcare in the UK and beyond. We look forward to attending the prestigious awards ceremony later this month!🎉 https://lnkd.in/eTMAYzzN

It is a well-known fact that there is a gender health gap when it comes to women’s healthcare. Health gaps are differences in the prevalence of disease, health outcomes, or access to healthcare across different groups. A report by the Health and Social Care Committee, 'Unheard: Women's journey through gynaecological cancer', highlighted the pressing need for change and reflection of the current state of women’s healthcare, and quality of cancer care. In the report they conclude that women's cancer concerns have been "dismissed, downplayed, and unheard," describing a "dangerous bias" against women that must be stamped out. The growing evidence and research highlights the devastating consequences of delayed diagnoses of gynaecological cancers. Misdiagnoses and dismissive responses have led to advanced-stage cancers, unnecessary suffering and ultimately the loss of lives. Ultimately, women know their own bodies and when they feel something is wrong, action needs to be taken. Knowledge is power. Awareness of how gynaecological cancers can present is key in improving survival. It is crucial that widespread public awareness campaigns continue to raise awareness of the symptoms not only for patients but for healthcare professionals too. We hope this will empower women to not only report their symptoms to their GP, but open a discussion for trust and mutual respect for women to be heard, and for action to be taken. As advocates for women's health, it's imperative that we amplify these voices and urge policymakers and healthcare leaders to continue to take decisive action. It is crucial that a deeper understanding of the diseases that affect women is shared more widely, and that this is reflected in policy and healthcare provision to provide equitable care. Every woman deserves timely and respectful care, and together, we can ensure that no one falls through the cracks. 💙 #WomensHealth #ClosingTheGap #HealthEquality #CancerAwareness

🌟 The U.S. Preventive Services Task Force (USPSTF) has finalised new recommendations for breast cancer screening, advocating for regular mammograms to start at age 40 instead of 50, every other year, until the age of 74. 🌟 Early detection saves lives, and these updated guidelines aim to ensure that more women have access to potentially life-saving screenings. The shift reflects a growing understanding of the importance of starting screenings earlier, particularly for women in their 40s, who are increasingly being diagnosed with breast cancer. The USPSTF also highlighted the need for further research into screening disparities faced by different racial groups in the U.S. and acknowledged that Black women, who are 40% more likely to die from breast cancer than white women, are more likely to be diagnosed in their 40s with more aggressive forms of the disease. Introducing regular breast screening earlier will undoubtedly save lives. These updated guidelines bring the US in alignment with many other organisations that recommend screening, or offering the choice to start screening, at age 40. They underscore the importance of prioritising early detection efforts to improve breast cancer outcomes for women across the country. For women in the UK, the NHS currently offers breast screening every 3 years, between the ages of 50 and 71. As the US makes strides towards improving screening protocols, it's crucial for other countries to follow suit. As healthcare providers, advocates, and individuals, let's continue to raise awareness about the importance of early detection and support initiatives such as this, which have the potential to guide healthcare policy through evidence-based medicine, making screening more accessible to all.💪  #BreastCancerAwareness #EarlyDetection #USPSTF #WomensHealth

“She hasn’t lost a battle, she wasn’t in a fight and she certainly wouldn’t want you to see her death as tragic. She was simply living.” In loving memory of Kris, we celebrate a life lived boldly, and whose boundless creativity inspired many. Kris was diagnosed with secondary breast cancer at the young age of 23, having been turned away from her GP several times for over a year. Despite facing a terminal prognosis, she channelled her passion into founding CoppaFeel!, driven by the belief that no one should endure the same fate due to delayed diagnosis. Through her tireless advocacy, Kris raised awareness about the importance of early detection and accurate diagnosis, sparking conversations about early detection and empowering individuals to take control of their health. In honouring Kris's legacy, we pledge to continue her mission in early and accurate cancer detection, striving for a world free from late diagnoses. We stand alongside CoppaFeel! in their crucial efforts to encourage, educate, and empower 18-24 year olds to normalise checking and recognise the early signs and symptoms of breast cancer. Our deepest sympathies go out to Kris’s family, friends, and everyone at CoppaFeel! HQ. Let us remember Kris for the joy she brought, the lives she touched, and the enduring legacy she leaves behind. And above all, let us honour her memory by sharing her timeless advice: "Trust your body, believe in hope, leave room for miracles." 💙